{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:14:52Z","timestamp":1764180892436,"version":"3.46.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04499-5","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:01:08Z","timestamp":1763982068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overlapping autoimmune encephalitis with tripartite autoantibody positivity (NMDAR, GFAP, mGluR5) associated with papillary thyroid carcinoma: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanxiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guonan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"4499_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol"},{"key":"4499_CR2","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s00415-018-8970-0","volume":"265","author":"C Bost","year":"2018","unstructured":"Bost C, et al. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. J Neurol. 2018;265:2190\u2013200.","journal-title":"J Neurol"},{"key":"4499_CR3","doi-asserted-by":"publisher","unstructured":"Mahadeen A, et al. \u201cAnti-N-methyl-D-aspartate Encephalitis Concomitantly with Tall-cell Variant Papillary Thyroid Carcinoma.\u201d Cureus. 2019;11(8):e5415.\u00a0https:\/\/doi.org\/10.7759\/cureus.5415.","DOI":"10.7759\/cureus.5415"},{"key":"4499_CR4","doi-asserted-by":"publisher","unstructured":"Chakraborty AP, et al. \u201cCapgras syndrome and confabulation unfurling anti NMDAR encephalitis with classical papillary thyroid carcinoma: First reported case.\u201d J Neuroimmunol. 2021;357: 577611.\u00a0https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577611.","DOI":"10.1016\/j.jneuroim.2021.577611"},{"key":"4499_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, et al. Autoimmune glial fibrillary acidic protein astrocytopathy. JAMA Neurol. 2016;73:1297\u2013307.","journal-title":"JAMA Neurol"},{"key":"4499_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","volume":"319","author":"I Carr","year":"1982","unstructured":"Carr I. The ophelia syndrome: memory loss in hodgkin\u2019s disease. Lancet. 1982;319:844\u20135.","journal-title":"Lancet"},{"key":"4499_CR7","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, et al. Antibodies to metabotropic glutamate receptor 5 in the ophelia syndrome. Neurology. 2011;77:1698\u2013701.","journal-title":"Neurology"},{"key":"4499_CR8","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, et al. Encephalitis with mGluR5 antibodies. Neurology. 2018;90:e1964\u201372.","journal-title":"Neurology"},{"key":"4499_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12883-022-02961-2","volume":"22","author":"P Bai","year":"2022","unstructured":"Bai P, et al. Anti-NMDAR encephalitis with GFAP\u03b1 igg: a case report. BMC Neurol. 2022;22:424.","journal-title":"BMC Neurol"},{"key":"4499_CR10","doi-asserted-by":"publisher","unstructured":"Gu Y, et al. \u201cAnti-metabotropic glutamate receptor 5 coexistent anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review.\u201d Front Immunol. 2025;16:1436246.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2025.1436246.","DOI":"10.3389\/fimmu.2025.1436246"},{"key":"4499_CR11","doi-asserted-by":"publisher","first-page":"919125","DOI":"10.3389\/fimmu.2022.919125","volume":"13","author":"J Fu","year":"2022","unstructured":"Fu J, et al. Case report: overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity. Front Immunol. 2022;13:919125.","journal-title":"Front Immunol"},{"key":"4499_CR12","doi-asserted-by":"publisher","unstructured":"Sinmaz N, et al. \u201cMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.\u201d J Neuroinflammation. 2016;13(1):219.\u00a0https:\/\/doi.org\/10.1186\/s12974-016-0678-4.","DOI":"10.1186\/s12974-016-0678-4"},{"key":"4499_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"4499_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, et al. Paraneoplastic anti\u2013N-methyl\u2010D\u2010aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336.","journal-title":"Ann Neurol"},{"key":"4499_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365.","journal-title":"Lancet Neurol"},{"key":"4499_CR16","doi-asserted-by":"publisher","unstructured":"Ma Y, et al. \u201cCytokine\/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.\u201d Front Immunol. 2023;13:1064007.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2022.1064007.","DOI":"10.3389\/fimmu.2022.1064007"},{"key":"4499_CR17","doi-asserted-by":"publisher","first-page":"577718","DOI":"10.1016\/j.jneuroim.2021.577718","volume":"360","author":"J Xiao","year":"2021","unstructured":"Xiao J, et al. Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retrospective study. J Neuroimmunol. 2021;360:577718.","journal-title":"J Neuroimmunol"},{"key":"4499_CR18","doi-asserted-by":"publisher","unstructured":"Ke G, et al. \u201cClinical characteristics and MRI features of autoimmune glial fibrillary acidic protein astrocytopathy: a case series of 34 patients.\u201d Front Neurol. 2024;15:1375971.\u00a0https:\/\/doi.org\/10.3389\/fneur.2024.1375971.","DOI":"10.3389\/fneur.2024.1375971"},{"key":"4499_CR19","doi-asserted-by":"publisher","unstructured":"Aldabbour B, El-Salem K, Aqaileh S, et al. Isolated subtle asymmetric slowing on EEG leading to a diagnosis of autoimmune encephalitis. Egypt J Neurol Psychiatry Neurosurg. 2020;56:46.\u00a0https:\/\/doi.org\/10.1186\/s41983-020-00180-5.","DOI":"10.1186\/s41983-020-00180-5"},{"key":"4499_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.26362","volume":"92","author":"E Maudes","year":"2022","unstructured":"Maudes E, et al. Human metabotropic glutamate receptor 5 antibodies alter receptor levels and behavior in mice. Ann Neurol. 2022;92:81\u20136.","journal-title":"Ann Neurol"},{"key":"4499_CR21","first-page":"740","volume":"11","author":"MJ Gandal","year":"2012","unstructured":"Gandal MJ, et al. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? Genes. Brain Behav. 2012;11:740\u201350.","journal-title":"Brain Behav"},{"key":"4499_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-244X-14-23","volume":"14","author":"KA Newell","year":"2014","unstructured":"Newell KA, Matosin N. Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics. BMC Psychiatry. 2014;14:23.","journal-title":"BMC Psychiatry"},{"key":"4499_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neubiorev.2015.02.006","volume":"52","author":"D Zantomio","year":"2015","unstructured":"Zantomio D, et al. Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD. Neurosci Biobehavioral Reviews. 2015;52:172\u20137.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"4499_CR24","doi-asserted-by":"publisher","unstructured":"Deng Y, et al. \u201cAnti-SOX1 antibodies-positive paraneoplastic neurological syndromes caused by thyroid carcinoma: A case report.\u201d Medicine.2023;102(16):e33499.\u00a0https:\/\/doi.org\/10.1097\/MD.0000000000033499.","DOI":"10.1097\/MD.0000000000033499"},{"key":"4499_CR25","doi-asserted-by":"publisher","unstructured":"Stauffer C, et al. \u201cNicotinic ganglionic acetylcholine receptor autoantibodies associated with paraneoplastic disease in a neuropsychiatric patient.\u201d BMJ Case Reports. 2021;14(5):e240824.\u00a0https:\/\/doi.org\/10.1136\/bcr-2020-240824.","DOI":"10.1136\/bcr-2020-240824"},{"key":"4499_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.5692\/clinicalneurol.cn-001977","volume":"64","author":"N Moro","year":"2024","unstructured":"Moro N, et al. Clinical features of five Japanese cases with leucine-rich glioma inactivated-1 (LGI1) antibody-positive encephalitis. Rinsho Shinkeigaku. 2024;64:714\u20138.","journal-title":"Rinsho Shinkeigaku"},{"key":"4499_CR27","doi-asserted-by":"publisher","unstructured":"Samad N, Jennifer W. \u201cAnti-AMPA receptor encephalitis associated with Medullary thyroid cancer.\u201d BMJ Case Reports. 2018:bcr2018225745.\u00a0https:\/\/doi.org\/10.1136\/bcr-2018-225745.","DOI":"10.1136\/bcr-2018-225745"},{"key":"4499_CR28","doi-asserted-by":"publisher","unstructured":"Fr\u00f6hlich E, Richard W. \u201cThyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.\u201d Front Immunol.\u00a02017;8:521.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2017.00521.","DOI":"10.3389\/fimmu.2017.00521"},{"key":"4499_CR29","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","volume":"263","author":"J Heine","year":"2016","unstructured":"Heine J, et al. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. J Neurol. 2016;263:2395\u2013402.","journal-title":"J Neurol"},{"key":"4499_CR30","unstructured":"Seery N et al. Rituximab use for relapse prevention in Anti-NMDAR Antibody-Mediated encephalitis. Neurol Neuroimmunol Neuroinflammation. 2025;12."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04499-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:12:06Z","timestamp":1764180726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04499-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4499"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04499-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Xiaolan People\u2019s Hospital of ZhongShan (The Fifth People\u2019s Hospital of ZhongShan). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, and all personal data were anonymized to ensure privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case and any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}